Pular para o conteúdo principal

ETHNOS_APP

Início • Busca • Periódicos • Lista 0

Sadaf G Sepanlou

Dados Biográficos

ID7751583
NOMESadaf G Sepanlou
PRENOMESSadaf G
SOBRENOMESepanlou
ASSINATURASEPANLOU S G
AFILIAÇÕESTehran University of Medical Sciences
ORCID0000-0002-3669-5129
VERIFICADOSim
TOTAL DE OBRAS63
TOTAL DE CITAÇÕES0
TOTAL COMO AUTOR63
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO2014
ANO MAIS RECENTE DE PUBLICAÇÃO2024
ÍNDICE H0
  • Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100

    Open Access•Natalia V Bhattacharjee, Austin E Schumacher et al.•ARTICLE•The Lancet•2024

    BACKGROUND: Accurate assessments of current and future fertility-including overall trends and changing population age structures across countries and regions-are essential to help plan for the profound social, economic, environmental, and geopolitical challenges that these changes will bring. Estimates and projections of fertility are necessary to inform policies involving resource and health-care needs, labour supply, education, gender equality,…

  • Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021

    Open Access•Mohsen Naghavi, Kanyin Liane Ong et al.•ARTICLE•The Lancet•2024

    BACKGROUND: Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mort…

  • Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the Covid-19 pandemic

    Open Access•Austin E Schumacher, Hmwe Hmwe Kyu et al.•ARTICLE•The Lancet•2024

    BACKGROUND: Estimates of demographic metrics are crucial to assess levels and trends of population health outcomes. The profound impact of the COVID-19 pandemic on populations worldwide has underscored the need for timely estimates to understand this unprecedented event within the context of long-term population health trends. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 provides new demographic estimates for 204 cou…

  • Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (Dalys), and healthy life expectancy (Hale) for 371 diseases and injuries in 204 countries and territor…

    Open Access•Alize J Ferrari, Damian Francesco Santomauro et al.•ARTICLE•The Lancet•2024

    BACKGROUND: Detailed, comprehensive, and timely reporting on population health by underlying causes of disability and premature death is crucial to understanding and responding to complex patterns of disease and injury burden over time and across age groups, sexes, and locations. The availability of disease burden estimates can promote evidence-based interventions that enable public health researchers, policy makers, and other professionals to im…

  • Worldwide trends in underweight and obesity from 1990 to 2022

    Open Access•Nowell H Phelps, Rosie Singleton et al.•ARTICLE•The Lancet•2024

    BACKGROUND: Underweight and obesity are associated with adverse health outcomes throughout the life course. We estimated the individual and combined prevalence of underweight or thinness and obesity, and their changes, from 1990 to 2022 for adults and school-aged children and adolescents in 200 countries and territories. METHODS: ). For school-aged children and adolescents, we report thinness (BMI 2 SD above the median). FINDINGS: From 1990 to 20…

  • Causes and predictors of premature death in the pars cohort study, Iran

    Open Access•Fateme Ziamanesh, Sadaf G Sepanlou et al.•ARTICLE•BMC Public Health•2024

    The predominant causes of premature mortality were IHD and stroke. To mitigate premature deaths, it is recommended to address both socioeconomic and behavioral factors simultaneously

  • Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050

    Open Access•Kanyin Liane Ong, Lauryn K Stafford et al.•ARTICLE•The Lancet•2023

    BACKGROUND: Diabetes is one of the leading causes of death and disability worldwide, and affects people regardless of country, age group, or sex. Using the most recent evidentiary and analytical framework from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD), we produced location-specific, age-specific, and sex-specific estimates of diabetes prevalence and burden from 1990 to 2021, the proportion of type 1 and type 2 diabetes…

  • Multimorbidity and associations with clinical outcomes in a middle-aged population in Iran

    Open Access•Maria Lisa Odland, Samiha Ismail et al.•ARTICLE•BMJ Global Health•2022

    BACKGROUND: As the populations of lower-income and middle-income countries age, multimorbidity is increasing, but there is little information on its long-term consequences. We aimed to show associations between multimorbidity and outcomes of mortality and hospitalisation in Iran, a middle-income country undergoing rapid economic transition. METHODS: We conducted a secondary analysis of longitudinal data collected in the Golestan Cohort Study. Dat…

  • Socioeconomic inequalities in prevalence, awareness, treatment and control of hypertension

    Open Access•Mahin Amini, Mahdi Moradinazar et al.•ARTICLE•BMC Public Health•2022

    The prevalence of HTN was higher among low-SES individuals, who also showed higher levels of awareness. However, treatment and control of HTN were more concentrated among those who had higher levels of SES, indicating that people at a higher risk of adverse event related to HTN (the low SES individuals) are not benefiting from the advantage of treatment and control of HTN. Such a gap between diagnosis (prevalence) and control (treatment and contr…

  • Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health

    Open Access•Katherine R Paulson, Katherine Paulson et al.•ARTICLE•The Lancet•2021

    BACKGROUND: Sustainable Development Goal 3.2 has targeted elimination of preventable child mortality, reduction of neonatal death to less than 12 per 1000 livebirths, and reduction of death of children younger than 5 years to less than 25 per 1000 livebirths, for each country by 2030. To understand current rates, recent trends, and potential trajectories of child mortality for the next decade, we present the Global Burden of Diseases, Injuries, a…

  • Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019

    Open Access•Marissa B Reitsma, Parkes J Kendrick et al.•ARTICLE•The Lancet•2021

    BACKGROUND: Ending the global tobacco epidemic is a defining challenge in global health. Timely and comprehensive estimates of the prevalence of smoking tobacco use and attributable disease burden are needed to guide tobacco control efforts nationally and globally. METHODS: We estimated the prevalence of smoking tobacco use and attributable disease burden for 204 countries and territories, by age and sex, from 1990 to 2019 as part of the Global B…

  • Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019

    Open Access•Bin Zhou, Rodrigo M Carrillo-Larco et al.•ARTICLE•The Lancet•2021

    BACKGROUND: Hypertension can be detected at the primary health-care level and low-cost treatments can effectively control hypertension. We aimed to measure the prevalence of hypertension and progress in its detection, treatment, and control from 1990 to 2019 for 200 countries and territories. METHODS: We used data from 1990 to 2019 on people aged 30-79 years from population-representative studies with measurement of blood pressure and data on blo…

  • Global, regional, and national burden of stroke and its risk factors, 1990–2019

    Open Access•Valery L Feigin, Benjamin A Stark et al.•ARTICLE•The Lancet Neurology•2021

    BACKGROUND: Regularly updated data on stroke and its pathological types, including data on their incidence, prevalence, mortality, disability, risk factors, and epidemiological trends, are important for evidence-based stroke care planning and resource allocation. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) aims to provide a standardised and comprehensive measurement of these metrics at global, regional, and national leve…

  • Global age-sex-specific fertility, mortality, healthy life expectancy (Hale), and population estimates in 204 countries and territories, 1950–2019

    Open Access•Haidong Wang, Kaja Abbas et al.•ARTICLE•The Lancet•2020

    BACKGROUND: Accurate and up-to-date assessment of demographic metrics is crucial for understanding a wide range of social, economic, and public health issues that affect populations worldwide. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 produced updated and comprehensive demographic assessments of the key indicators of fertility, mortality, migration, and population for 204 countries and territories and selected sub…

  • Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories

    Open Access•Andrea Rodriguez-Martinez, Andrea Rodriguez‐Martinez et al.•ARTICLE•The Lancet•2020

    BACKGROUND: Comparable global data on health and nutrition of school-aged children and adolescents are scarce. We aimed to estimate age trajectories and time trends in mean height and mean body-mass index (BMI), which measures weight gain beyond what is expected from height gain, for school-aged children and adolescents. METHODS: For this pooled analysis, we used a database of cardiometabolic risk factors collated by the Non-Communicable Disease …

  • Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017

    Open Access•Joan B Soriano, Parkes J Kendrick et al.•ARTICLE•The Lancet Respiratory Medicine•2020

    BACKGROUND: Previous attempts to characterise the burden of chronic respiratory diseases have focused only on specific disease conditions, such as chronic obstructive pulmonary disease (COPD) or asthma. In this study, we aimed to characterise the burden of chronic respiratory diseases globally, providing a comprehensive and up-to-date analysis on geographical and time trends from 1990 to 2017. METHODS: Using data from the Global Burden of Disease…

  • Five insights from the Global Burden of Disease Study 2019

    Open Access•Christopher J L Murray, Cristiana Abbafati et al.•ARTICLE•The Lancet•2020

  • Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019

    Open Access•Gregory A Roth, George A Mensah et al.•ARTICLE•Journal of the American College…•2020

    Cardiovascular diseases (CVDs), principally ischemic heart disease (IHD) and stroke, are the leading cause of global mortality and a major contributor to disability. This paper reviews the magnitude of total CVD burden, including 13 underlying causes of cardiovascular death and 9 related risk factors, using estimates from the Global Burden of Disease (GBD) Study 2019. GBD, an ongoing multinational collaboration to provide comparable and consisten…

  • Global, regional, and national burden of chronic kidney disease, 1990–2017

    Open Access•Boris Bikbov, Caroline Purcell et al.•ARTICLE•The Lancet•2020

    BACKGROUND: Health system planning requires careful assessment of chronic kidney disease (CKD) epidemiology, but data for morbidity and mortality of this disease are scarce or non-existent in many countries. We estimated the global, regional, and national burden of CKD, as well as the burden of cardiovascular disease and gout attributable to impaired kidney function, for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. We use…

  • Global burden of 87 risk factors in 204 countries and territories, 1990–2019

    Open Access•Christopher J L Murray, Aleksandr Y Aravkin et al.•ARTICLE•The Lancet•2020

    BACKGROUND: Rigorous analysis of levels and trends in exposure to leading risk factors and quantification of their effect on human health are important to identify where public health is making progress and in which cases current efforts are inadequate. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 provides a standardised and comprehensive assessment of the magnitude of risk factor exposure, relative risk, and attribu…

  • Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019

    Open Access•Theo Vos, Stephen S Lim et al.•ARTICLE•The Lancet•2020

    BACKGROUND: In an era of shifting global agendas and expanded emphasis on non-communicable diseases and injuries along with communicable diseases, sound evidence on trends by cause at the national level is essential. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides a systematic scientific assessment of published, publicly available, and contributed data on incidence, prevalence, and mortality for a mutually exclusive…

  • Global, regional, and national burden of neurological disorders, 1990–2016

    Open Access•Valery L Feigin, Emma Nichols et al.•ARTICLE•The Lancet Neurology•2019

    BACKGROUND: Neurological disorders are increasingly recognised as major causes of death and disability worldwide. The aim of this analysis from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 is to provide the most comprehensive and up-to-date estimates of the global, regional, and national burden from neurological disorders. METHODS: We estimated prevalence, incidence, deaths, and disability-adjusted life-years (DALYs;…

  • Past, present, and future of global health financing

    Open Access•Alenda Y Chang, Angela Y Chang et al.•ARTICLE•The Lancet•2019

    BACKGROUND: Comprehensive and comparable estimates of health spending in each country are a key input for health policy and planning, and are necessary to support the achievement of national and international health goals. Previous studies have tracked past and projected future health spending until 2040 and shown that, with economic development, countries tend to spend more on health per capita, with a decreasing share of spending from developme…

  • Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017

    Open Access•Christina Fitzmaurice, Global Burden of Disease Cancer Collaboration et al.•ARTICLE•JAMA Oncology•2019

    Importance Cancer and other noncommunicable diseases (NCDs) are now widely recognized as a threat to global development. The latest United Nations high-level meeting on NCDs reaffirmed this observation and also highlighted the slow progress in meeting the 2011 Political Declaration on the Prevention and Control of Noncommunicable Diseases and the third Sustainable Development Goal. Lack of situational analyses, priority setting, and budgeting hav…

  • Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories

    Open Access•Tahvi D Frank, Tahvi Frank et al.•ARTICLE•The Lancet HIV•2019

    BACKGROUND: Understanding the patterns of HIV/AIDS epidemics is crucial to tracking and monitoring the progress of prevention and control efforts in countries. We provide a comprehensive assessment of the levels and trends of HIV/AIDS incidence, prevalence, mortality, and coverage of antiretroviral therapy (ART) for 1980-2017 and forecast these estimates to 2030 for 195 countries and territories. METHODS: We determined a modelling strategy for ea…

Próximo

Sem obras proeminentes nesta página.

  • Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013

    Open Access•Christopher J L Murray, Katrina F Ortblad et al.•ARTICLE•The Lancet•2014

  • Global, regional, and national levels and causes of maternal mortality during 1990–2013

    Open Access•Nicholas J Kassebaum, Amelia Bertozzi-Villa et al.•ARTICLE•The Lancet•2014

  • Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013

    Open Access•Marie Ng, Tom Fleming et al.•ARTICLE•The Lancet•2014

  • Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013

    Open Access•Mohammad H Forouzanfar, Lily Alexander et al.•ARTICLE•The Lancet•2015

  • Global, regional, and national disability-adjusted life years (Dalys) for 306 diseases and injuries and healthy life expectancy (Hale) for 188 countries, 1990–2013

    Open Access•Christopher J L Murray, Ryan M Barber et al.•ARTICLE•The Lancet•2015

  • Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013

    Open Access•Theo Vos, Ryan M Barber et al.•ARTICLE•The Lancet•2015

  • Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015

    Open Access•Haidong Wang, Zulfiqar A Bhutta et al.•ARTICLE•The Lancet•2016

    BACKGROUND: Established in 2000, Millennium Development Goal 4 (MDG4) catalysed extraordinary political, financial, and social commitments to reduce under-5 mortality by two-thirds between 1990 and 2015. At the country level, the pace of progress in improving child survival has varied markedly, highlighting a crucial need to further examine potential drivers of accelerated or slowed decreases in child mortality. The Global Burden of Disease 2015 …

  • Global, regional, and national disability-adjusted life-years (Dalys) for 315 diseases and injuries and healthy life expectancy (Hale), 1990–2015

    Open Access•Nicholas J Kassebaum, Megha Arora et al.•ARTICLE•The Lancet•2016

    BACKGROUND: Healthy life expectancy (HALE) and disability-adjusted life-years (DALYs) provide summary measures of health across geographies and time that can inform assessments of epidemiological patterns and health system performance, help to prioritise investments in research and development, and monitor progress toward the Sustainable Development Goals (SDGs). We aimed to provide updated HALE and DALYs for geographies worldwide and evaluate ho…

  • Global, regional, and national levels of maternal mortality, 1990–2015

    Open Access•Nicholas J Kassebaum, Ryan M Barber et al.•ARTICLE•The Lancet•2016

    BACKGROUND: In transitioning from the Millennium Development Goal to the Sustainable Development Goal era, it is imperative to comprehensively assess progress toward reducing maternal mortality to identify areas of success, remaining challenges, and frame policy discussions. We aimed to quantify maternal mortality throughout the world by underlying cause and age from 1990 to 2015. METHODS: We estimated maternal mortality at the global, regional, …

  • Measuring the health-related Sustainable Development Goals in 188 countries

    Open Access•Stephen S Lim, Kate Allen et al.•ARTICLE•The Lancet•2016

    BACKGROUND: In September, 2015, the UN General Assembly established the Sustainable Development Goals (SDGs). The SDGs specify 17 universal goals, 169 targets, and 230 indicators leading up to 2030. We provide an analysis of 33 health-related SDG indicators based on the Global Burden of Diseases, Injuries, and Risk Factors Study 2015 (GBD 2015). METHODS: We applied statistical methods to systematically compiled data to estimate the performance of…

  • Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015

    Open Access•Haidong Wang, Mohsen Naghavi et al.•ARTICLE•The Lancet•2016

    BACKGROUND: Improving survival and extending the longevity of life for all populations requires timely, robust evidence on local mortality levels and trends. The Global Burden of Disease 2015 Study (GBD 2015) provides a comprehensive assessment of all-cause and cause-specific mortality for 249 causes in 195 countries and territories from 1980 to 2015. These results informed an in-depth investigation of observed and expected mortality patterns bas…

  • Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015

    Open Access•Mohammad H Forouzanfar, Ashkan Afshin et al.•ARTICLE•The Lancet•2016

    BACKGROUND: The Global Burden of Diseases, Injuries, and Risk Factors Study 2015 provides an up-to-date synthesis of the evidence for risk factor exposure and the attributable burden of disease. By providing national and subnational assessments spanning the past 25 years, this study can inform debates on the importance of addressing risks in context. METHODS: We used the comparative risk assessment framework developed for previous iterations of t…

  • Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015

    Open Access•Theo Vos, Christine Allen et al.•ARTICLE•The Lancet•2016

    BACKGROUND: Non-fatal outcomes of disease and injury increasingly detract from the ability of the world's population to live in full health, a trend largely attributable to an epidemiological transition in many countries from causes affecting children, to non-communicable diseases (NCDs) more common in adults. For the Global Burden of Diseases, Injuries, and Risk Factors Study 2015 (GBD 2015), we estimated the incidence, prevalence, and years liv…

  • Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries

    Open Access•Nancy Fullman, Ryan M Barber et al.•ARTICLE•The Lancet•2017

    BACKGROUND: The UN's Sustainable Development Goals (SDGs) are grounded in the global ambition of "leaving no one behind". Understanding today's gains and gaps for the health-related SDGs is essential for decision makers as they aim to improve the health of populations. As part of the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016), we measured 37 of the 50 health-related SDG indicators over the period 1990-2016 for 188…

  • Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016

    Open Access•Theo Vos, Amanuel Alemu Abajobir et al.•ARTICLE•The Lancet•2017

    BACKGROUND: As mortality rates decline, life expectancy increases, and populations age, non-fatal outcomes of diseases and injuries are becoming a larger component of the global burden of disease. The Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) provides a comprehensive assessment of prevalence, incidence, and years lived with disability (YLDs) for 328 causes in 195 countries and territories from 1990 to 2016. METHO…

  • Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015

    Open Access•Marissa B Reitsma, Nancy Fullman et al.•ARTICLE•The Lancet•2017

    BACKGROUND: The scale-up of tobacco control, especially after the adoption of the Framework Convention for Tobacco Control, is a major public health success story. Nonetheless, smoking remains a leading risk for early death and disability worldwide, and therefore continues to require sustained political commitment. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) offers a robust platform through which global, regional, and na…

  • Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015

    Open Access•Ryan M Barber, Nancy Fullman et al.•ARTICLE•The Lancet•2017

    BACKGROUND: National levels of personal health-care access and quality can be approximated by measuring mortality rates from causes that should not be fatal in the presence of effective medical care (ie, amenable mortality). Previous analyses of mortality amenable to health care only focused on high-income countries and faced several methodological challenges. In the present analysis, we use the highly standardised cause of death and risk factor …

  • Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016

    Open Access•Mohsen Naghavi, Amanuel Alemu Abajobir et al.•ARTICLE•The Lancet•2017

    BACKGROUND: Monitoring levels and trends in premature mortality is crucial to understanding how societies can address prominent sources of early death. The Global Burden of Disease 2016 Study (GBD 2016) provides a comprehensive assessment of cause-specific mortality for 264 causes in 195 locations from 1980 to 2016. This assessment includes evaluation of the expected epidemiological transition with changes in development and where local patterns …

  • Worldwide trends in blood pressure from 1975 to 2015

    Open Access•Bin Zhou, James Bentham et al.•ARTICLE•The Lancet•2017

    BACKGROUND: Raised blood pressure is an important risk factor for cardiovascular diseases and chronic kidney disease. We estimated worldwide trends in mean systolic and mean diastolic blood pressure, and the prevalence of, and number of people with, raised blood pressure, defined as systolic blood pressure of 140 mm Hg or higher or diastolic blood pressure of 90 mm Hg or higher. METHODS: For this analysis, we pooled national, subnational, or comm…

  • Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016

    Open Access•Emmanuela Gakidou, Ashkan Afshin et al.•ARTICLE•The Lancet•2017

    BACKGROUND: The Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) provides a comprehensive assessment of risk factor exposure and attributable burden of disease. By providing estimates over a long time series, this study can monitor risk exposure trends critical to health surveillance and inform policy debates on the importance of addressing risks in context. METHODS: We used the comparative risk assessment framework dev…

  • Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016

    Open Access•Haidong Wang, Amanuel Alemu Abajobir et al.•ARTICLE•The Lancet•2017

    BACKGROUND: Detailed assessments of mortality patterns, particularly age-specific mortality, represent a crucial input that enables health systems to target interventions to specific populations. Understanding how all-cause mortality has changed with respect to development status can identify exemplars for best practice. To accomplish this, the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) estimated age-specific and …

  • Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015

    Mohammad H Forouzanfar, Patrick Liu et al.•ARTICLE•JAMA•2017

    Importance: Elevated systolic blood (SBP) pressure is a leading global health risk. Quantifying the levels of SBP is important to guide prevention policies and interventions. Objective: To estimate the association between SBP of at least 110 to 115 mm Hg and SBP of 140 mm Hg or higher and the burden of different causes of death and disability by age and sex for 195 countries and territories, 1990-2015. Design: A comparative risk assessment of hea…

  • Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015

    Christina Fitzmaurice, Global Burden of Disease Cancer Collaboration et al.•ARTICLE•JAMA Oncology•2017

    IMPORTANCE: Cancer is the second leading cause of death worldwide. Current estimates on the burden of cancer are needed for cancer control planning. OBJECTIVE: To estimate mortality, incidence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs) for 32 cancers in 195 countries and territories from 1990 to 2015. EVIDENCE REVIEW: Cancer mortality was estimated using vital registration system dat…

  • Global, regional, and national disability-adjusted life-years (Dalys) for 333 diseases and injuries and healthy life expectancy (Hale) for 195 countries and territories, 1990–2016

    Open Access•Simon I Hay, Amanuel Alemu Abajobir et al.•ARTICLE•The Lancet•2017

    BACKGROUND: Measurement of changes in health across locations is useful to compare and contrast changing epidemiological patterns against health system performance and identify specific needs for resource allocation in research, policy development, and programme decision making. Using the Global Burden of Diseases, Injuries, and Risk Factors Study 2016, we drew from two widely used summary measures to monitor such changes in population health: di…

  • Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016

    Open Access•Leandra Abarca-Gómez, Ziad Abdeen et al.•ARTICLE•The Lancet•2017

    BACKGROUND: Underweight, overweight, and obesity in childhood and adolescence are associated with adverse health consequences throughout the life-course. Our aim was to estimate worldwide trends in mean body-mass index (BMI) and a comprehensive set of BMI categories that cover underweight to obesity in children and adolescents, and to compare trends with those of adults. METHODS: We pooled 2416 population-based studies with measurements of height…

Medicine (60 obras) · Environmental health (55 obras) · Demography (37 obras) · Population (37 obras) · Burden of disease (36 obras) · Disease (35 obras) · Disease burden (24 obras) · Global Maternal and Child Health (22 obras) · Public health (19 obras) · Global health (18 obras)

Ethnos_APP • Projeto Open Source • Licença MIT • Frontend v2.0.0 • Privacidade e Cookies • Documentação da API: api.ethnos.app/docs • Código da API: GitHub • DOI: 10.5281/zenodo.17049435 • Código do Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae